Living related liver transplantation for recurrent hepatocellular carcinoma in a normal liver

Donavon Hess, Abhinav Humar, Timothy D. Sielaff

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The role of liver transplantation for hepatocellular carcinoma (HCC) is evolving. In patients with advanced liver disease and early stage HCC, transplantation offers the best hope for cure. A living donor offers the optimal approach to a timely transplant, before disease progression obviates the potential benefit. But extending the indications beyond those designated by the United Network for Organ Sharing (UNOS) for liver transplantation for HCC is controversial [Hepatology 2001: 33: 1073; Liver Transplant 2000: 6: S1]. Cadaver split techniques and use of living donors are potentially compelling ways to test the limitations of liver transplantation for HCC, without notably reducing the cadaver organ pool. Herein, we report a rare case of a patient who developed a well-differentiated HCC in a normal liver. After resection of the index lesion and, later, of a remote recurrent lesion, a living donor liver transplant was offered. The natural history of this lesion and the management of transplantation in this setting are discussed.

Original languageEnglish (US)
Pages (from-to)240-242
Number of pages3
JournalClinical Transplantation
Issue number3
StatePublished - 2002


  • Hepatocellular carcinoma
  • Liver transplantation
  • Living related liver transplantation
  • Recurrent hepatocellular carcinoma


Dive into the research topics of 'Living related liver transplantation for recurrent hepatocellular carcinoma in a normal liver'. Together they form a unique fingerprint.

Cite this